Management of primary breast cancer: an update.
Based on results of trials emerged during the last 2 years and on data presented at the 8th International Conference on Primary Therapy of Early Breast Cancer held in 2003 in St. Gallen, a summary of current knowledge and controversies in the management of breast cancer is given. The following topics are covered: screening, biology, surgery, radiation therapy, primary systemic therapy, and adjuvant therapy (biological therapies, chemotherapy, endocrine therapies including ovarian ablation, and their interactions).
Thürlimann
B
B
Senologie-Zentrum Ostschweiz (SENZO), Kantonsspital, St. Gallen, Switzerland. beat.thuerlimann@kssg.ch
Müller
A
A
Senn
H-J
HJ
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000628:therapy*; D017024:Chemotherapy, Adjuvant / Q000379:methods*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D010346:Patient Care Management / Q000379:methods* / Q000639:trends*
D000970:Antineoplastic Agents; D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists